Downloads
Current Presentations
Date | Title | File |
---|---|---|
Nov 18, 2024
|
Immatics Corporate Presentation November 2024
|
|
Nov 18, 2024
|
TCR Bispecific Molecule TCER® IMA402 Targeting PRAME - Phase 1 Dose Escalation Clinical Data Update
|
IMA402 Release_4Q2024_FINAL2.pdf 937.5 KB
|
Nov 08, 2024
|
Enhanced Pharmacology Data of Next-generation IMA203CD8 TCR-T Monotherapy Targeting PRAME
|
|
Nov 08, 2024
|
Combination of a TCR-engineered Autologous PRAME-targeting T Cell Therapy with a PRAME-encoding mRNA for the Treatment of Solid Tumors
|
|
Nov 08, 2024
|
ACTengine® IMA203 TCR-T Targeting PRAME Shows Deep and Durable Anti-Tumor Activity in Heavily Pretreated Solid Cancer Patients
|
|
Oct 10, 2024
|
ACTengine® IMA203 TCR-T Targeting PRAME in PD1 Refractory Metastatic Melanoma - Phase 1b Dose Expansion Clinical Data Update
|
|
Sep 16, 2024
|
TCER® IMA401 Targeting MAGEA4/8 - Phase 1 Dose Escalation Clinical Data Update
|
|
Nov 08, 2023
|
ACTengine® IMA203 & IMA203CD8 TCR-T Monotherapy Targeting PRAME - Phase 1 Interim Data Update
|
|
Nov 08, 2023
|
ACTengine® IMA203 Clinical Data Update at Society for Melanoma Research Congress, November 2023
|
|
Nov 10, 2022
|
PRAME Target Presentation at SITC Annual Meeting, November 2022
|
Archive
Date | Title | File |
---|---|---|
Nov 10, 2020
|
Immatics ACTolog® IMA101 Phase-1-Data at the 35th Annual SITC conference
|
Media Materials
Immatics Campus Sternwarte Reception - Tübingen, Germany
Sternwarte 1.jpg 2.6 MB
Immatics Mass Spectrometry
Immatics Campus Sternwarte Exterior - Tübingen, Germany
Sternwarte 2.jpg 2.6 MB
Immatics Injection Vials
Injection Vials.jpg 2.1 MB
Immatics Logo
Immatics Logo 15.3 KB
Immatics Stafford - Houston, Texas
Immatics Stafford 1.jpg 23.1 MB